Drug-coated balloon for new coronary blockages
Part of Heart & circulation clinical trials.
This trial is testing a special balloon coated with medication to treat newly formed blockages in the heart's arteries. The medication may help keep the artery open after the balloon opens it during a standard procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are willing and able to give informed consent.
- You are eligible for a standard heart artery opening procedure (percutaneous coronary intervention, or PCI).
- You can commit to all follow-up visits as required by the study.
- If you are a woman who can become pregnant, you must agree to use reliable birth control for 12 months after the procedure.
- Your blocked artery must be a new blockage in a native coronary artery, not a previously stented one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying how well drug-coated balloons work for people with coronary artery disease. It looks at their use in many different situations, including new blockages, re-narrowed stents, and complex cases. The goal is to see if they are a good option for opening blocked arteries.
This trial studies whether a drug-coated balloon can treat certain coronary artery narrowings in adults with chronic (long-term) coronary disease. It may help prevent re-narrowing after the procedure for people whose tests show the blockage is significant and needs treatment.
This trial studies whether a drug-coated balloon can treat a brand-new (de novo) blockage in the coronary arteries. If you may qualify, it could offer a way to reduce problems from this blockage using a device that delivers medicine during treatment.
This trial tests a special balloon coated with medicine to open blocked coronary arteries (blood vessels to the heart). The procedure uses ultrasound and imaging guidance to help doctors decide whether to use the drug-coated balloon alone, which may reduce the need for stents and future complications.
This trial tests a special balloon coated with a drug (sirolimus) to treat blockages in small heart arteries. If the balloon is successful, it may help keep the artery open without needing a permanent stent.
This trial tests how the way a drug-coated balloon is used during a heart procedure affects outcomes for people with stable heart disease or unstable angina. It may help doctors find the best technique to keep arteries open.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.